Podcasts about influenza vaccination

This episode discusses four MMWR reports. First, 2024-2025 COVID-19 vaccination provides additional protection against COVID-19-associated emergency department/urgent care encounters and hospitalizations. Second, this season's flu vaccines protect against flu-related medical visits and hospitalizations. Third, a new CDC report finds that 13% of children who have died from seasonal flu this season had influenza-associated encephalopathy or encephalitis, a potentially severe neurologic complication. Last, as HPV vaccination has increased, a steep decline in cervical precancers has occurred.

The Flu Vaccine: Science at its Worst   Richard Gale and Gary Null Progressive Radio Network, December 20, 2024   Joshua Hadfield was a normal, healthy developing child as a toddler. In the midst of the H1N1 swine flu frenzy and the media fear mongering about the horrible consequences children face if left unvaccinated, the Hadfield family had Joshua vaccinated with Glaxo's Pandermrix influenza vaccine.  Within weeks, Joshua could barely wake up, sleeping up to nineteen hours a day. Laughter would trigger seizures. Joshua was diagnosed with narcolepsy, “an incurable, debilitating condition” associated with acute brain damage.[1]  Looking back, Pandermrix was a horrible vaccine.  Research indicates that it was associated with a 1400% increase in narcolepsy risk. A medical team at Finland's National Institute for Health and Welfare recorded 800 cases of narcolepsy associated with this vaccine.  Aside from the engineered viral antigens, the other vaccine ingredients are most often found to be the primary culprits to adverse vaccine reactions. The Finnish research, on the other hand, indicated that the vaccine's altered viral nucleotide likely contributed to the sudden rise in sleeping sickness.[2] Although Pandermrix was pulled from the market for its association with narcolepsy and cataplexy (sudden muscle weakness), particularly in children, it should never have been approved and released in the first place.  The regulatory fast tracking of the HINI flu vaccines is a classic, and now common, example of regulatory negligence by nations' health officials. The failure of proper regulatory evaluation and oversight resulted in Joshua and over 1,000 other people becoming disabled for life. Settlements to cover lawsuits exceeded 63 million pounds in the UK alone.  No one should feel complacent and assume flu vaccine risks only affect young children. Sarah Behie was 20 years old after receiving a flu shot.  Three weeks later her health deteriorated dramatically. Diagnosed with Guillain-Barre syndrome, a not uncommon adverse effect of influenza vaccination, four years later Sarah remains paralyzed from the waist down, incapable of dressing and feeding herself, and rotting away in hospitals and nursing homes.[3]  Flu vaccines are perhaps the most ineffective vaccine on the market.  Repeatedly we are told by health officials that the moral argument for its continued use is for “the greater good,” although this imaginary good has never been defined scientifically. Year to year, how effective any given seasonal flu vaccine will be is a throw of the dice. Annual flu vaccine efficacy rates in the US have demonstrated significant variability. Data from the CDC reveal efficacy estimates of approximately 39% for the 2020–2021 season, 37% for 2021–2022, 52% for 2022–2023, and a preliminary estimate of 50% for the 2023–2024 season.  Preliminary CDC estimates for this flu season estimates 34% likely efficacy. Although these are CDC's figures, independent figures are consistently much lower. At their best, flu vaccines in recent years are around 50% effective according to official health analysis. During some seasons, vaccine efficacy is a bust. For example, the 2014-2015 flu season strain match was such a failure that the CDC warned the American public that the vaccine was only 23% effective.[4]  Nevertheless, these rates underscore the vaccine's inconsistent protection. Studies such as those by Skowronski and Belongia further highlight flu vaccines' variability and force to question whether the vaccine is capable of providing any reliable protection.[5,6] Moreover, Cochrane Collaboration reviews, known for their rigorous analyses, consistently find that flu vaccines reduce influenza-like illness by only about 1% in healthy adults and have negligible impact on hospitalizations and mortality rates. This limited efficacy raises critical concerns about the vaccine's utility, particularly when weighed against its risks.  Perhaps the most useless flu vaccine that should have never been approved was Medimmune's live attenuated flu vaccine (LAIV) FluMist, which the CDC later had removed from the market because it was found to so ineffective—only 3 percent according to an NBC report.[6] However the real reason may be more dire, and this a fundamental problem of all live and attenuated vaccines: these vaccines have been shown to “shed” and infect people in contact with the vaccinated persons, especially those with compromised immune systems.  Consequently, both the unvaccinated and the vaccinated are at risk.  The CDC acknowledges this risk and warns “Persons who care for severely immunosuppressed persons who require a protective environment should not receive LAIV, or should avoid contact with such persons for 7 days after receipt, given the theoretical risk for transmission of the live attenuated vaccine virus.”[7]  According to the FDA's literature on FluMist, the vaccine was not studied for immunocompromised individuals (yet was still administered to them), and has been associated with acute allergic reactions, asthma, Guillain-Barre, and a high rate of hospitalizations among children under 24 months – largely due to upper respiratory tract infections.  Other adverse effects include pericarditis, congenital and genetic disorders, mitochondrial encephalomyopathy or Leigh Syndrome, meningitis, and others.[8]  The development and promotion of the influenza vaccine was never completely about protecting the public. It has been the least popular vaccine in the US, including among healthcare workers. Rather, similar to the mumps vaccine in the MMR, it has been the cash cow for vaccine makers.  Determining the actual severity of any given flu season is burdened by federal intentional confusion to mislead the public.  The CDC's first line of propaganda defense to enforce flu vaccinations is to exaggerate flu infections as the cause of preventable deaths.   However, validating this claim is near impossible because the CDC does not differentiate deaths caused by influenza infection and deaths due to pneumonia.  On its website, the CDC lumps flu and pneumonia deaths together, currently estimated at 51,000 per year. The large majority of these were pneumonia deaths of elderly patients. Yet in any given year, only 3-18% of suspected influenza infections actually test positive for a Type A or B influenza strain.[9]  As an aside, it is worth noting that during the first two years of the COVID-19 pandemic, an extraordinary and unprecedented phenomenon occurred: influenza infections, which have long been a seasonal health challenge, seemingly disappeared. Federal health agencies such as the CDC attributed this sharp decline in flu cases to the implementation of non-pharmaceutical interventions (NPIs) like mask-wearing, social distancing, and widespread lockdowns. However, this explanation raises critical questions about its plausibility. If these measures were effective enough to virtually eliminate influenza, why did they not similarly prevent the widespread transmission of SARS-CoV-2? This contradiction highlights the need to critically examine the possible explanations behind the anomaly, questioning whether the disappearance of the flu was truly a result of public health measures or due to other factors such as diagnostic practices, viral interference, and disruptions to seasonal flu patterns. If these interventions were indeed effective, their impact should not have been so starkly selective between two similarly transmitted viruses. This contradiction undermines the plausibility of attributing the disappearance of flu cases solely to NPIs. A more plausible explanation for the disappearance of flu cases lies in the diagnostic focus on SARS-CoV-2 during the pandemic. Individuals presenting with flu-like symptoms were overwhelmingly diagnosed for COVID-19 with faulty PCR testing methods rather than influenza, as public health resources were directed toward managing the pandemic. This prioritization inevitably led to a significant underreporting of flu cases. Furthermore, the symptoms of influenza and COVID-19 overlap significantly, including fever, cough, and fatigue. In the absence of influenza testing, many flu cases were wrongly diagnosed as COVID-19, further inflating SARS-CoV-2 case numbers while contributing to the perceived disappearance of the flu.  One of the more controversial findings in recent flu vaccine research involves the phenomenon of viral interference, wherein vaccinated individuals may become more susceptible to other respiratory pathogens. To date there is only one gold standard clinical trial with the flu vaccine that compares vaccinated vs. unvaccinated, and it is not good news for the CDC, the vaccine makers, and the push to booster everyone with the Covid-19 mRNA vaccines. This Hong Kong funded double-blind placebo controlled study followed the health conditions of vaccinated and unvaccinated children between the ages of 6-15 years for 272 days. The trial concluded the flu vaccine holds no health benefits. In fact, those vaccinated with the flu virus were observed to have a 550% higher risk of contracting non-flu virus respiratory infections. Among the vaccinated children, there were 116 flu cases compared to 88 among the unvaccinated; there were 487 other non-influenza virus infections, including coronavirus, rhinovirus, coxsackie, and others, among the vaccinated versus 88 with the unvaccinated.[10]  This single study alone poses a scientifically sound warning and rationale to avoid flu vaccines at all costs. It raises a further question: how many Covid-19 cases could be directly attributed to weakened immune systems because of prior flu vaccination? A 2019 study conducted by the US Armed Forces investigated the relationship between influenza vaccination and susceptibility to other respiratory infections, including coronaviruses. Analyzing data from over 9,000 individuals, the researchers found that people who received the flu vaccine were more likely to test positive for certain non-influenza respiratory viruses. Notably, influenza vaccination was associated with an increased likelihood of contracting coronaviruses and human metapneumovirus.[11] These findings suggest a complex interaction between influenza vaccination and susceptibility to different respiratory pathogens, and challenges the belief that flu vaccines provide greater benefits over risks. The same researchers' follow up study in in 2020 furthermore concluded that “vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus.[12] Additional recent studies, such as those by Bodewes, which identified immune interference due to repeated annual flu vaccinations,[13] and Shinjoh, which highlighted increased viral interference in vaccinated children, provide further evidence of this relationship.[14] These findings challenge the prevailing assumption that flu vaccination has only positive effects on immune health and raise important questions about the broader implications of repeated annual vaccination. In a follow up study after the H1N1 swine flu scare, Canadian researcher Dr. Danuta Skowronski noted that individuals with a history of receiving consecutive seasonal flu shots over several years had an increased risk of becoming infected with H1N1 swine flu.  Skowronski commented on the findings, “policy makers have not yet had a chance to fully digest them [the study's conclusions] or understand the implications.”  He continued, “Who knows, frankly? The wise man knows he knows nothing when it comes to influenza, so you always have to be cautious in speculating.”[15] There is strong evidence suggesting that all vaccine clinical trials carried out by manufacturers fall short of demonstrating vaccine efficacy accurately. And when they are shown to be efficacious, it is frequently in the short term and offer only partial or temporary protection. According to an article in the peer-reviewed Journal of Infectious Diseases, the only way to evaluate vaccines is to scrutinize the epidemiological data obtained from real-life conditions. In other words, researchers simply cannot -- or will not -- adequately test a vaccine's effectiveness and immunogenicity prior to its release onto an unsuspecting public.[16] According to Dr. Tom Jefferson, who formerly led the Cochrane Collaboration's vaccine analyses, it makes little sense to keep vaccinating against seasonal influenza based on the evidence.[17] Jefferson has also endorsed more cost-effective and scientifically-proven means of minimizing the transmission of flu, including regular hand washing and wearing masks. There is also substantial peer-reviewed literature supporting the supplementation of Vitamin D.  Dr. Jefferson's conclusions are backed by former Johns Hopkins University School of Medicine scientist Peter Doshi, PhD, in the British Journal of Medicine. In his article Doshi questions the flu vaccine paradigm stating:  “Closer examination of influenza vaccine policies shows that although proponents employ the rhetoric of science, the studies underlying the policy are often of low quality, and do not substantiate officials' claims. The vaccine might be less beneficial and less safe than has been claimed, and the threat of influenza appears overstated.”[18]         A significant body of research proves that receiving the flu shot does not reduce mortality among seniors.[19] One particularly compelling study was carried out by scientists at the federal National Institutes of Health (NIH) and published in the Journal of the American Medical Association (JAMA). Not only did the study indicate that the flu vaccine did nothing to prevent deaths from influenza among seniors, but that flu mortality rates increased as a greater percentage of seniors received the shot.[20] Dr. Sherri Tenpenny reviewed the Cochrane Database reviews on the flu vaccine's efficacy. In a review of 51 studies involving over 294,000 children, there was “no evidence that injecting children 6-24 months of age with a flu shot was any more effective than placebo. In children over 2 years of age, flu vaccine effectiveness was 33 percent of the time preventing flu. In children with asthma, inactivated flu vaccines did not prevent influenza related hospitalizations in children. The database shows that children who received the flu vaccine were at a higher risk of hospitalization than children who did not receive the vaccine.[21]  In a separate study involving 400 asthmatic children receiving a flu vaccine and 400 who were not immunized, there was no difference in the number of clinic and emergency room visits and hospitalizations between the two groups.[22]  In 64 studies involving 66,000 adults, “Vaccination of healthy adults only reduced risk of influenza by 6 percent and reduced the number of missed work days by less than one day. There was a change in the number of hospitalizations compared to the non-vaccinated. In further studies of elderly adults residing in nursing homes over the course of several flu seasons, flu vaccinations were insignificant for preventing infection.[23] Today, the most extreme wing of the pro-vaccine community continue to diligently pursue mandatory vaccination across all 50 states.  During the flu season, the debate over mandatory vaccination becomes most heated as medical facilities and government departments attempt to threaten employees and schools who refuse vaccination. Although this is deeply worrisome to those who advocate their Constitutional rights to freedom of choice in their healthcare, there are respectable groups opposing mandatory flu shots.  The Association of American Physicians and Surgeons “objects strenuously to any coercion of healthcare personnel to receive influenza immunization. It is a fundamental human right not to be subjected to medical interventions without fully informed consent.”  The good news is that the majority of Americans have lost confidence in the CDC after the agency's dismal handling of the Covid-19 pandemic. Positive endorsement of the CDC would plummet further if the public knew the full extent of CDC officials lying to Congress and their conspiracy to commit medical fraud for two decades to cover=up evidence of an autism-vaccine association.  When considering the totality of evidence, the benefit-risk ratio of flu vaccination becomes increasingly problematic. The poor and inconsistent efficacy rates, combined with the potential for serious adverse reactions and the phenomenon of viral interference, clearly indicates that the vaccine does not deliver the public health benefits it promises. Public health strategies must balance the benefits of vaccination against its risks, particularly for vulnerable populations such as children and pregnant women.  Imagine the tens of thousands of children and families who would have been saved from life-long neurological damage and immeasurable suffering if the CDC was not indebted to protecting the pharmaceutical industry's toxic products and was in fact serving Americans' health and well-being? One step that can be taken to begin dismantling the marriage between the federal health agencies and drug companies is to simply refuse the flu vaccine and protect ourselves by adopting a healthier lifestyle during the flu season.    NOTES [1] http://yournewswire.com/boy-awarded-174000-after-flu-vaccine-causes-permanent-brain-damage/  [2]  http://www.globalresearch.ca/finnish-scientists-identify-link-between-glaxosmithklines-swine-flu-vaccine-pandemrix-and-narcolepsy/5423154 [3] http://sharylattkisson.com/woman-paralyzed-after-flu-shot-receives-11-million-for-treatment/ [4]  http://america.aljazeera.com/articles/2014/12/3/flu-vaccine-ineffective.html  [5]Skowronski DM, Leir S, et al. Influenza vaccine effectiveness by A (H3N2) phylogenetic subcluster and prior vaccination history: 2016–2017 and 2017–2018 epidemics in Canada. J Infectious Diseases, 2021; 225(8), 1387–1397. [6] Belongia EA, Skowronski DM, et al. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Review of Vaccines, 2023; 16(7), 743–759. [7]  Barbara Lo Fisher, The Emerging Risks of Live Virus and Virus Vectored Vaccines.  National Vaccine Information Center, 2014  [8]  http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM294307.pdf  [9] Barbara Lo Fisher, “CDC Admits Flu Shots Fail Half the Time.”  NVIC, October 19, 2016 [10] http://gaia-health.com/gaia-blog/2013-06-02/flu-vax-causes-5-5-times-more-respiratory-infections/  [11] Wolff GG. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season. Vaccine. 2019 Oct 10;38(2):350–354.   [12] Wolff GG. (2020). Influenza vaccination and respiratory virus interference among Department of Defense personnel. Vaccine, 2020 38(2), 350-354.  [13] Bodwes F, Janssens Y, et al. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Frontiers in Immunology, 2021 13, 959379. DOI: 10.3389/fimmu.2022.959379  [14] Sinojoh M, Sugaya N, et al. Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in the 2022/23 season in Japan: The first season of co-circulation of influenza and COVID-19. Vaccine, 2022; 41(1), 100-107.  [15]  http://www.cbc.ca/news/health/flu-shot-linked-to-higher-incidence-of-flu-in-pandemic-year-1.1287363 [16]   Weinberg GA, Szilagyi PG. Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap. J Infect Dis 20210;201.1: 1607-610.  [17] ‘A Whole Industry Is Waiting For A Pandemic', Der Spiegel, http://www.spiegel.de/international/world/0,1518,637119-2,00.html, [18] Dolshi P. "Influenza: Marketing Vaccine by Marketing Disease." BMJ 2013;346: F3037.  [19] Simonsen L, Reichert T, et al. . Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population. Arch Intern Med Archives 2005;165(3): 265.  [20] Glezen WP, Simonsen L. Commentary: Benefits of Influenza Vaccine in US Elderly--new Studies Raise Questions. Internat J Epidemiology2006;35(2): 352-53. [21] 105th International Conference of the American Thoracic Sociey, May 15-20, 2009 (quoted in , Sherri Tenpenny.  “The Truth about Flu Shots”.  Idaho Observer, June 1, 2009)  [22] ibid  [23] Ibid.

This is the first time that a proposal for different timings for flu shots has been introduced in India. It hinges on the analysis of influenza data across India between 2004-2023.

In this episode, Ayesha spoke with William Schaffner, MD, Professor of Preventive Medicine Health Policy and Professor in the Division of Infectious Diseases at Vanderbilt University; and Kelly Moore, MD, MPH, President and CEO at Immunize.org and Associate Professor of Health Policy at Vanderbilt University.Dr. Schaffner and Dr. Moore discussed the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation of a trivalent influenza vaccine strain selection, as opposed to a typical quadrivalent vaccine, with the 2024/2025 influenza season reflecting the removal of the B/Yamagata strain. A renowned infectious disease expert, having appeared on numerous media outlets including CNN particularly during the COVID-19 pandemic, Dr. Schaffner's primary interest has been the prevention of infectious diseases domestically and globally in both pediatric and adult populations. After residency training and a fellowship in infectious diseases at Vanderbilt University, Dr. Schaffner served in the US Public Health Service as an epidemic intelligence service officer with the Centers for Disease Control and Prevention (CDC) in Atlanta. After that tour of duty, Dr. Schaffner joined the faculty at Vanderbilt, establishing a long collaboration with the Tennessee Department of Health. Dr. Schaffner has been a member of numerous expert advisory committees that established national vaccine policy. Dr. Schaffner is also the current medical director and past president of the National Foundation for Infectious Diseases and has served on the executive board for the Infectious Diseases Society of America. Prominent infectious disease expert Dr. Moore served for 14 years as the director of the Tennessee Immunization Program and later founded her own consulting company, The Vaccine Advisor, to advise public health and industry before her current role as president and CEO of immunize.org, a leading nonprofit organization focused on national and global vaccine policy and immunization program implementation. Dr. Moore has served in a variety of immunization policy advisory roles with the World Health Organization (WHO) since 2016, including as chair of its Immunization Practices Advisory Committee. Dr. Moore is a graduate of the Vanderbilt School of Medicine and the Harvard School of Public Health. She completed her public health leadership training as an epidemic intelligence service and preventive me

Listen to ideas from the members of Sri Lankan community in Australia talking about, their experiences and medical opinions on influenza vaccination - ඉන්ෆ්ලුවෙන්සා එන්නත සම්බන්ධයෙන් තිබෙන අත්දැකීම් සහ මේ පිළිබඳව තිබෙන වෛද්‍ය අදහස් වලට සවන් දෙන්න මෙම අප්‍රේල් මාසයේ SBS සිංහල ගුවන් විදුලියේ 'විනිවිද' ජනතා මත විමසුම තුළින්

The McCullough Report with Dr. Peter McCullough – What happens when you mix medicine with politics? — you get politics. We find out firsthand in the last part of the show when we have Dr. Mavrakakis introduce libertarianism to the Report. More about Dr. Mavrakakis from her conference website: “Irene Mavrakakis, M.D is the Founder of Liberty Speaks and Delaware Initiative for Science and Ethics. Promoting the anti-war message and advocating for Free and Equal Elections...

The McCullough Report with Dr. Peter McCullough – What happens when you mix medicine with politics? — you get politics. We find out firsthand in the last part of the show when we have Dr. Mavrakakis introduce libertarianism to the Report. More about Dr. Mavrakakis from her conference website: “Irene Mavrakakis, M.D is the Founder of Liberty Speaks and Delaware Initiative for Science and Ethics. Promoting the anti-war message and advocating for Free and Equal Elections...

Dr. Centor discusses encouraging patients to receive influenza vaccination with Drs. Mark Tenforde and Fatimah Dawood.

News

In this compelling podcast episode, we spoke with  Kristin Reihman, MD — physician, mother, author, and Lyme disease survivor — as she candidly shares her personal journey as both a patient and doctor. Beyond merely treating symptoms, Dr. Reihman advocates for a holistic approach to health, challenging the conventional norms of the allopathic medical system. Having recovered herself from a debilitating case of Lyme over a decade ago, Dr. Reihman knows all too well what it is to live with a body that feels like it's falling apart, a brain that has forgotten how to do simple math, and the fear that you're going to die from an illness that is invisible to most people. She also knows how to make a complete recovery, and has done that for herself. Now, she is on a mission to help as many people as possible recover their own most vibrant versions of themselves, and get back to living their amazing lives. She shares her favorite tools, practices, and mindset shifts for whole-person healing and wellness in her book, on weekly episodes of her Healing Grove Podcast, and in the online communities she cultivates, including the Healing Grove Membership, on Instagram, and in her latest offering, the Life After Lyme Coaching Program. We delve into the intricacies of American physicians' training, highlighting the need for a more comprehensive understanding of health. Dr. Kristin Reihman's story takes an unexpected turn as she shares her principled decision to leave a local hospital network and traditional practice due to her stance against a mandatory vaccine. This bold move becomes the focal point of our conversation, sparking reflections on values, medical freedom and divine intervention.Kristin Reihman, MDFamily Hope CenterThe Healing Grove Podcast: Kristin Reihman, MD - YouTubeInstagram @kristinreihmanmdLink to Ebook: Life After LymeReceive $10.00 off of Life After Lyme ebook at checkout: RadGenPodcastNote: This podcast episode is designed solely for informational and educational purposes, without endorsing or promoting any specific medical treatments. We strongly advise consulting with a qualified healthcare professional before making any medical decisions or taking any actions.*If you are in crisis or believe you have an emergency, please contact your doctor or dial 911. If you are contemplating suicide, call 1-800-273-TALK to speak with a trained and skilled counselor.RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / X (Twitter)Substack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically Genuine—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS—----------ADDITIONAL RESOURCES8:00 - Lyme disease microbiology - Wikipedia11:30 - Tick-Borne Co-Infections are the Rule, Not the Exception15:30 - Everything about Lyme disease is steeped in controversy. Now some doctors are too afraid to treat patients - ILADS16:00 - ILADS Treatment Guidelines21:00 - House (TV Series 2004–2012) - IMDb26:30 - Guillain-Barre Syndrome after Influenza Vaccination in Adults (P12-7.006) | Neurology33:00 - The Emerging Role of Microbial Biofilm in Lyme Neuroborreliosis - PMC.35:00 - A Grounded Theory Study of Homeopathic Practitioners' Perceptions and Experiences of the Homeopathic Consultation - PMC43:00 - Four remarkable plants of the Amazon52:00 - Vaccine Effectiveness: How Well Do Flu Vaccines Work? | CDC54:00 - Radiolab: An update on hookworms57:00 - Does The Moon Affect Humans? – Cleveland Clinic1:04:00 - Stop Suffering by Giving Up Your Attack Thoughts | Psychology Today1:10:00 - Is This Your Child?: Rapp M.D., Doris1:14:00 - Family Hope Center1:19:00 - Hormesis - an overview | ScienceDirect Topics1:22:00 - Radically Genuine Podcast with Dr. Roger McFillin | 58. Mental benefits of doing hard things

Did you know that children are the main disseminators of influenza in the households and in the community? Credit available for this activity expires: 10/31/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997863?ecd=bdc_podcast_libsyn_mscpedu

Guest: Natalia Castillo Almeida, MD Influenza can increase the risk of hospitalization and disease severity, specifically for high-risk patients. Fortunately, the influenza vaccine can help combat this. Join Dr. Natalia Castillo Almeida, an Assistant Professor in the Division of Infectious Diseases at the University of Nebraska School of Medicine, as she shares key data on hospitalization rates and recommendations for vaccination.

To claim your mainpro credit please use the link below: https://cfpclearn.ca/podcast/bs-medicine-episode-537-a-jab-for-your-cad-influenza-vaccination-for-the-prevention-of-cardiovascular-events/  In episode 537, Mike and James invite Ricky Turgeon back to the podcast to talk about the impact of the influenza vaccination on cardiovascular events in both primary and secondary prevention. The best evidence is in secondary prevention. Tune-in to hear the numbers.

In episode 537, Mike and James invite Ricky Turgeon back to the podcast to talk about the impact of the influenza vaccination on cardiovascular events in both primary and secondary prevention. The best evidence is in secondary prevention. Tune-in to hear the numbers. Show Notes 1) Tools for Practice A Jab for Your CAD: Influenza […]

In this week's View, Dr. Eagle discusses a clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions on renal denervation in the management of hypertension in adults, then looks at the risk of surgical mitral valve repair for primary mitral regurgitation. Finally, Dr. Eagle explores an observational study that examines primary prevention of acute cardiovascular events by influenza vaccination.  Subscribe to Eagle's Eye View  

Practices are well into the flu vaccination season by now, but how often do we actually stop and think about what is in the vaccinations that we give, and how we know when flu is circulating? Dr Toni Hazell talks to Professor Simon de Lusignan of the RCGP Research and Surveillance Centre (RSC). They discuss the strains of flu that are in the vaccine, our expectations for uptake this year and why we have moved to a quadrivalent vaccine. Simon also talks about the work of the RSC, who are always looking for more practices to be part of their network. If you would like to enquire about joining the RCGP Research and Surveillance Centre, please email practiceenquiries@phc.ox.ac.uk You can view the RSC's Virology Dashboard here: https://tinyurl.com/34p2xjbb CSL Seqirus has funded these podcasts and has been involved in discussion for the topic of this podcast. The content has been prepared independently by the RCGP without any input from CSL Seqirus. This podcast is intended for healthcare professionals and is disseminated by media determined by the RCGP.

In this podcast, Richard Newton discusses Equine influenza bi-annual boosters: What does the evidence tell us? and Equine influenza vaccination catches an autumn cold!  But must get over it as soon as it can.

Join your cohosts, Dr. Starlin and Sarah, as they interview Robin Williams, Epidemiology Surveillance Coordinator for Nebraska Department of Health and Human Services about Influenza for the 22-23 season. This podcast is brought to you by Nebraska ICAP. This team is grant funded to provide infection control and infectious disease support for facilities across Nebraska. You can find more information about Nebraska at https://icap.nebraskamed.com/ Don't forget to follow us on Twitter at @dirty_drinks and reach out to us if you want to be a guest on the show! The views expressed in this podcast are those of the guests and hosts. These views do not represent the official standing of any public, state or federal entity.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Natalia Castillo Almeida, MD Patients in urban communities often face challenges when accessing influenza vaccines. But there are ways we can help address those geographic and socioeconomic barriers. Joining Dr. Charles Turck to share key strategies for improving influenza vaccination rates in urban communities is Dr. Natalia Castillo, Assistant Professor in the Division of Infectious Diseases at University of Nebraska Medical Center.

Host: Paul P. Doghramji, MD, FAAFP Guest: Suchitra Rao, MD Since the onset of the COVID-19 pandemic, there's been a slow decline in influenza vaccine uptake, particularly among children. But vaccination for our youngest patients is absolutely critical, especially amid this season's potential tridemic between COVID-19, RSV, and the flu. So what concerns or misconceptions do parents have that may make them more hesitant to get their child vaccinated, and what counseling strategies can we use to address those concerns? Here with Dr. Paul Doghramji to discuss how we can increase influenza vaccination rates among pediatric patients is Dr. Suchitra Rao, Associate Professor of Pediatrics and Pediatric Hospital Medicine at the University of Colorado School of Medicine.

In this podcast Dr George Kassianos (National Immunisation Lead for the RCGP and President of the British Global & Travel Health Association) chats with Dr Dirk Pilat (Medical Director for Professional Development of the RCGP), about the importance of immunising pregnant patients, the choice available and its benefits. Influenza and SARS-CoV-2 and the benefits of the various vaccines available for pregnant patients are discussed. CSL Seqirus has funded these podcasts and has been involved in discussion for the topic of this podcast. The content has been prepared independently by the RCGP without any input from CSL Seqirus. This podcast is intended for healthcare professionals and is disseminated by media determined by the RCGP.

People who work in long-term care know that staff vaccinations are key to stopping the spread of viruses like influenza. But how do you increase vaccination rates in your facility? Fellowship Community infection preventionist Audrey Fernald joins us to share how her facility successfully increased staff vaccination rates.Click here to watch a video recording of this episode.Check out our other interviews by visiting qualityinsights.org/qin/multimedia.  This material was prepared by Quality Insights, a Quality Innovation Network - Quality Improvement Organization under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this material do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. Publication number 12SOW-QI-GEN-091522-CC-A

Welcome to the first episode of the Brain podcast- the official podcast for the journal Brain and sister journal Brain Communications. We are joined by Professor Roland Liblau who will tell us about his group's mouse model of narcolepsy in which autoimmune inflammation of orexinergic neurons is induced by influenza vaccination. Check out the full article on the Brain website: https://academic.oup.com/brain/article-abstract/145/6/2018/6581499 This episode was hosted, edited and produced by Xin You Tai; co-hosted by Sarosh Irani; co-produced by Joanne Bell; original music by Ammar Al-Chalabi.  

Unfortunately, many patients with CAD do not receive the influenza vaccine every year.  And many patients being discharged from hospital after an acute coronary event don't receive it either. The IAMI (Influenza Vaccination After Myocardial Infarction) study was the first, large, randomized, double-blind, placebo-controlled, multi-center trial to investigate whether influenza vaccination could reduce the rate of cardiovascular events in high-risk adults with CAD. Guest Authors:  Noelle Cordova, PharmD and Laura McAuliffe, PharmD, BCACP, CDCES Music by Good Talk

Did you get your flu-shot this season? If you didn't ... you are in the majority! In the 2021/2022 flu season, only 26.7 percent of Albertans rolled-up their sleeve for the flu shot. so, what will low influenza vaccination rates and coverage mean for Albertans in the years to come? With insight, we were joined by Dr. Jia Hu, CEO and Co-Founder of 19 To Zero, Corporate Medical Director, Cleveland Clinic Canada. 

ESC Wrap-up Part II: EMPEROR-Preserved, and the STEP, Guide-HF, and IAMI trials, are discussed by John Mandrola, MD, in this week's podcast. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I - HFpEF - EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough https://www.medscape.com/viewarticle/957405 - Empagliflozin in Heart Failure with a Preserved Ejection Fraction https://www.nejm.org/doi/full/10.1056/NEJMoa2107038 II - BP Targets - STEP: Lowering Blood Pressure Below 130 mm Hg Shows CV Benefit https://www.medscape.com/viewarticle/957566 - Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://www.nejm.org/doi/full/10.1056/NEJMoa2111437 III- PA Catheter Monitoring - GUIDE-HF: CardioMEMS-Guided Meds Fall Short in Mild to Moderate Heart Failure https://www.medscape.com/viewarticle/957390 - Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial https://doi.org/10.1016/S0140-6736(21)01754-2 - Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial https://doi.org/10.1016/S0140-6736(11)60101-3 IV - Influenza Vaccine - Seasonal Flu Vax Cuts Post-MI Mortality in IAMI Trial https://www.medscape.com/viewarticle/957575 - Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial https://doi.org/10.1161/CIRCULATIONAHA.121.057042 - Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis https://pubmed.ncbi.nlm.nih.gov/20332404/ You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine. https://www.medscape.com/features/public/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Dass Gesundheitsrisiken gesellschaftlich ungleich verteilt sind, ist lange bekannt. Trotzdem trägt die Pandemiepolitik dem nicht Rechnung. Das Coronavirus trifft arme und bildungsferne Menschen besonders hart, und das nicht nur beim Infektionsrisiko, sondern auch, was den Krankheitsverlauf angeht. In einer Sonderfolge spricht Wissenschaftsredakteurin Korinna Hennig mit dem Medizinsoziologen Nico Dragano über die sozioökonomische Seite der Corona-Krise. Er erklärt, was man aus früheren Pandemien hätte lernen können, welche Rolle Nahverkehr und Arbeitsplätze spielen - und was man anders machen müsste. Die Hintergrundinformationen • Sozioökonomische Ungleichheit und COVID-19 | Robert Koch-Insititut: Eine Übersicht über den internationalen Forschungsstand https://edoc.rki.de/handle/176904/6965 • Risikofaktoren und Covid-19-Tests in Großbritannien | Marc Chadeau-Hyam, Barbara Bodinier, Joshua Elliott, Matthew D Whitaker, Ioanna Tzoulaki, Roel Vermeulen, Michelle Kelly-Irving, Cyrille Delpierre und Paul Elliott: "Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data", erschienen August 2020 bei Oxford Academic https://academic.oup.com/ije/article/49/5/1454/5894660?login=true • Covid-19 Inzidenz und Sterberate in Abhängigkeit von schlechten Wohnverhältnissen in den USA | Khansa Ahmad, Sebhat Erqou, Nishant Shah, Umair Nazir, Alan R. Morrison, Gaurav Choudhary und Wen-Chih Wu: "Association of poor housing conditions with COVID-19 incidence and mortality across US counties", erschienen November 2020 bei PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241327 • Mobilität und Nahverkehr in der Corona-Pandemie in New York | Karla Therese L. Sy, Micaela E. Martinez, Benjamin Rader und Laura F. White: "Socioeconomic disparities in subway use and COVID-19 outcomes in New York City", erschienen Mai 2020 auf medRxiv https://www.medrxiv.org/content/10.1101/2020.05.28.20115949v1.full.pdf • Mobilität und Ungleichheit | Serina Chang, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky und Jure Leskovec: "Mobility network models of COVID-19 explain inequities and inform reopening", erschienen November 2020 bei Nature https://www.nature.com/articles/s41586-020-2923-3.pdf • Studie aus Israel zum Zugang zu Tests und Infektionsrisiken in der Corona-Pandemie | Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman, Manfred S. Green, Gabriel Chodick und Dani Cohen: "A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021", erschienen August 2020 in The Lancet Regional Health - Europe auf ScienceDirect https://www.sciencedirect.com/science/article/pii/S2666776221001071 • Risikofaktoren und Krankheitsverläufe in Schweden | Jonathan Bergman, Marcel Ballin, Anna Nordström und Peter Nordström: "Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study", erschienen März 2021 in European Journal of Epidemiology volume bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00732-w • Risikofaktoren und Krankheitsverläufe in Großbritannien | Joshua Elliott, Barbara Bodinier, Matthew Whitaker, Cyrille Delpierre, Roel Vermeulen, Ioanna Tzoulaki, Paul Elliott und Marc Chadeau-Hyam: "COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors", erschienen Februar 2021 im European Journal of Epidemiology bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00722-y • Erhöhtes Risiko eines COVID-19-bedingten Krankenhausaufenthaltes für Arbeitslose | Morten Wahrendorf, Christoph J. Rupprecht, Olga Dortmann, Maria Scheider und Nico Dragano: Eine Analyse von Krankenkassendaten von 1,28 Mio. Versicherten in Deutschland, erschienen Januar 2021 im Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz auf Springer Nature https://link.springer.com/article/10.1007%2Fs00103-021-03280-6 • Inzidenz und Sterblichkeit in Abhängigkeit vom sozialen Status in Chile | Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud, Pablo A. Marquet, Caroline O. Buckee und Mauricio Santillana: "Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile", erschienen Mai 2021 bei Science https://science.sciencemag.org/content/372/6545/eabg5298.abstract • Impfungen und Bevölkerungsgruppen - Studie aus Italien | Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, Luca Maraniello, Filippo Ansaldi, Vincenzo Baldo, Paolo Bonanni, Giovanna Elisa Calabrò, Claudio Costantino, Chiara de Waure, Giovanni Gabutti, Vincenzo Restivo, Caterina Rizzo, Francesco Vitale und Riccardo Grassi: "Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey", erschienen November 2020 bei MDPI https://www.mdpi.com/2076-393X/8/4/711 • Grippe und Impfung bei 65+ | Jason M Nagata, Isabel Hernández-Ramos, Anand Sivasankara Kurup, Daniel Albrecht, Claudia Vivas-Torrealba und Carlos Franco-Paredes, "Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data", erschienen April 2013 bei BMC (Springer Nature) https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-388 • Daten aus früheren Pandemien - Hohe Sterberaten bei niedrigem sozialen Status | "Social inequality - a forgotten factor in pandemic influenza preparedness", erschienen Juni 2017 bei Tidsskrift for Den norske legeforening Oslo https://tidsskriftet.no/2017/05/global-helse/social-inequality-forgotten-factor-pandemic-influenza-preparedness • Frühere Pandemien - SARS | Grace Wong Bucchianeri: "Is SARS a Poor Man's Disease? Socioeconomic Status and Risk Factors for SARS Transmission", erschienen 2010 in Forum for Health Economics & Policy https://www.degruyter.com/document/doi/10.2202/1558-9544.1209/html • Frühere Pandemien - Blick auf Chicago 1918 | Kyra H. Grantz, Madhura S. Rane, Henrik Salje, Gregory E. Glass, Stephen E. Schachterle, and Derek A. T. Cummings: "Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918", erschienen November 2016 bei PNAS https://www.pnas.org/content/113/48/13839.short • Ungleichheit und Epidemien als Herausforderung für die globale Sicherheit | Sandra Crouse Quinn und Supriya Kumar: "Health Inequalities and Infectious Disease Epidemics: A Challenge for Global Health Security", erschienen September 2014 im Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science bei Mary Ann Liebert, Inc., publishers https://www.liebertpub.com/doi/abs/10.1089/bsp.2014.0032

Dass Gesundheitsrisiken gesellschaftlich ungleich verteilt sind, ist lange bekannt. Trotzdem trägt die Pandemiepolitik dem nicht Rechnung. Das Coronavirus trifft arme und bildungsferne Menschen besonders hart, und das nicht nur beim Infektionsrisiko, sondern auch, was den Krankheitsverlauf angeht. In einer Sonderfolge spricht Wissenschaftsredakteurin Korinna Hennig mit dem Medizinsoziologen Nico Dragano über die sozioökonomische Seite der Corona-Krise. Er erklärt, was man aus früheren Pandemien hätte lernen können, welche Rolle Nahverkehr und Arbeitsplätze spielen - und was man anders machen müsste. Die Hintergrundinformationen • Sozioökonomische Ungleichheit und COVID-19 | Robert Koch-Insititut: Eine Übersicht über den internationalen Forschungsstand https://edoc.rki.de/handle/176904/6965 • Risikofaktoren und Covid-19-Tests in Großbritannien | Marc Chadeau-Hyam, Barbara Bodinier, Joshua Elliott, Matthew D Whitaker, Ioanna Tzoulaki, Roel Vermeulen, Michelle Kelly-Irving, Cyrille Delpierre und Paul Elliott: "Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data", erschienen August 2020 bei Oxford Academic https://academic.oup.com/ije/article/49/5/1454/5894660?login=true • Covid-19 Inzidenz und Sterberate in Abhängigkeit von schlechten Wohnverhältnissen in den USA | Khansa Ahmad, Sebhat Erqou, Nishant Shah, Umair Nazir, Alan R. Morrison, Gaurav Choudhary und Wen-Chih Wu: "Association of poor housing conditions with COVID-19 incidence and mortality across US counties", erschienen November 2020 bei PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241327 • Mobilität und Nahverkehr in der Corona-Pandemie in New York | Karla Therese L. Sy, Micaela E. Martinez, Benjamin Rader und Laura F. White: "Socioeconomic disparities in subway use and COVID-19 outcomes in New York City", erschienen Mai 2020 auf medRxiv https://www.medrxiv.org/content/10.1101/2020.05.28.20115949v1.full.pdf • Mobilität und Ungleichheit | Serina Chang, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky und Jure Leskovec: "Mobility network models of COVID-19 explain inequities and inform reopening", erschienen November 2020 bei Nature https://www.nature.com/articles/s41586-020-2923-3.pdf • Studie aus Israel zum Zugang zu Tests und Infektionsrisiken in der Corona-Pandemie | Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman, Manfred S. Green, Gabriel Chodick und Dani Cohen: "A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021", erschienen August 2020 in The Lancet Regional Health - Europe auf ScienceDirect https://www.sciencedirect.com/science/article/pii/S2666776221001071 • Risikofaktoren und Krankheitsverläufe in Schweden | Jonathan Bergman, Marcel Ballin, Anna Nordström und Peter Nordström: "Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study", erschienen März 2021 in European Journal of Epidemiology volume bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00732-w • Risikofaktoren und Krankheitsverläufe in Großbritannien | Joshua Elliott, Barbara Bodinier, Matthew Whitaker, Cyrille Delpierre, Roel Vermeulen, Ioanna Tzoulaki, Paul Elliott und Marc Chadeau-Hyam: "COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors", erschienen Februar 2021 im European Journal of Epidemiology bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00722-y • Erhöhtes Risiko eines COVID-19-bedingten Krankenhausaufenthaltes für Arbeitslose | Morten Wahrendorf, Christoph J. Rupprecht, Olga Dortmann, Maria Scheider und Nico Dragano: Eine Analyse von Krankenkassendaten von 1,28 Mio. Versicherten in Deutschland, erschienen Januar 2021 im Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz auf Springer Nature https://link.springer.com/article/10.1007%2Fs00103-021-03280-6 • Inzidenz und Sterblichkeit in Abhängigkeit vom sozialen Status in Chile | Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud, Pablo A. Marquet, Caroline O. Buckee und Mauricio Santillana: "Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile", erschienen Mai 2021 bei Science https://science.sciencemag.org/content/372/6545/eabg5298.abstract • Impfungen und Bevölkerungsgruppen - Studie aus Italien | Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, Luca Maraniello, Filippo Ansaldi, Vincenzo Baldo, Paolo Bonanni, Giovanna Elisa Calabrò, Claudio Costantino, Chiara de Waure, Giovanni Gabutti, Vincenzo Restivo, Caterina Rizzo, Francesco Vitale und Riccardo Grassi: "Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey", erschienen November 2020 bei MDPI https://www.mdpi.com/2076-393X/8/4/711 • Grippe und Impfung bei 65+ | Jason M Nagata, Isabel Hernández-Ramos, Anand Sivasankara Kurup, Daniel Albrecht, Claudia Vivas-Torrealba und Carlos Franco-Paredes, "Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data", erschienen April 2013 bei BMC (Springer Nature) https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-388 • Daten aus früheren Pandemien - Hohe Sterberaten bei niedrigem sozialen Status | "Social inequality - a forgotten factor in pandemic influenza preparedness", erschienen Juni 2017 bei Tidsskrift for Den norske legeforening Oslo https://tidsskriftet.no/2017/05/global-helse/social-inequality-forgotten-factor-pandemic-influenza-preparedness • Frühere Pandemien - SARS | Grace Wong Bucchianeri: "Is SARS a Poor Man's Disease? Socioeconomic Status and Risk Factors for SARS Transmission", erschienen 2010 in Forum for Health Economics & Policy https://www.degruyter.com/document/doi/10.2202/1558-9544.1209/html • Frühere Pandemien - Blick auf Chicago 1918 | Kyra H. Grantz, Madhura S. Rane, Henrik Salje, Gregory E. Glass, Stephen E. Schachterle, and Derek A. T. Cummings: "Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918", erschienen November 2016 bei PNAS https://www.pnas.org/content/113/48/13839.short • Ungleichheit und Epidemien als Herausforderung für die globale Sicherheit | Sandra Crouse Quinn und Supriya Kumar: "Health Inequalities and Infectious Disease Epidemics: A Challenge for Global Health Security", erschienen September 2014 im Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science bei Mary Ann Liebert, Inc., publishers https://www.liebertpub.com/doi/abs/10.1089/bsp.2014.0032

This podcast summarises the article 'Equine influenza vaccination in the UK – current practices may leave horses with suboptimal immunity’ by Wilson et al.

In this episode, Professor Paul Effler provides a brief update on the COVID and Influenza vaccinations. Professor Paul Effler is the Senior Medical Advisor, Communicable Disease Control Directorate, WA Department of Health and Clinical Professor, University of Western Australia. Information correct as at 17 February 2021.

A/Prof John Litt AM, Public Health Physician and Associate Professor, Discipline of General Practice at Flinders University will go through the factors that contribute to lower influenza vaccine effectiveness. John will then describe the manufacturing process of two influenza vaccines – cell vs egg, and outline the possible advantages of the cell culture influenza vaccine. Current data on influenza vaccine effectiveness and flu vaccination in the age of COVID-19 will also be covered. See omnystudio.com/listener for privacy information.

Influenza outbreaks place a significant annual burden on the Australian healthcare system. There is well documented evidence that increasing rates of influenza vaccination, especially amongst high risk patients will decrease the number of confirmed cases of influenza, reduce hospital admissions, associated costs and death. Despite this, under usage of immunisation programs continues to be a significant public health concern with inadequate time to attend a venue for vaccination being identified as a significant contributor to less than ideal vaccination rates. The Royal Brisbane and Women's Hospital pharmacy service has input into ambulatory outpatient services, making it ideal for providing opportunistic vaccinations to patients in a hospital outpatient setting. The aim was to investigate the impact of such a service on increasing access for high-risk patients to receive their annual influenza vaccination. Learn more To watch Kim's interview, visit the Clinical Excellence Showcase website. For information about the project, visit their page on our Improvement Exchange. Please subscribe to ‘Clinical Excellence Showcase' wherever you digest your podcasts, rate and review on iTunes and follow us on social media: Facebook, Twitter and Instagram.

I stole some time to tackle a pressing issue for rheumatologists - to hold or not to hold immunosuppression in patients who are receiving a COVID19 vaccination.  We obviously don't have any data on this, but I have always loved this study on influenza vaccination.  PDFs at ebrheum.com/twts and follow me on twitter @ebrheum! 

In this podcast Dr George Kassianos discuss ways of mass vaccination with Jackie Reeve, Dr Ivan Aloysius and Dr Anish Kotecha. The circulation of the SARS-Cov-2 virus in our communities during the current influenza season has made it necessary to change the ways we carry our influenza vaccinations. One solution is to carry out mass vaccinations in large premises that offer space and car park facilities. The group discuss logistics when carrying out such mass vaccinations, as well as effective practice in organising the practice influenza vaccination clinics. 

In this episode, Scott Solomon, Ankeet Bhatt, and Orly Vardeny are joined by William Schaffner to discuss the importance of influenza vaccination particularly this year in the midst of the coronavirus disease 2019 pandemic.

FDA 治疗高度耐药肺结核的新药NEJM 巴罗萨韦对流感家庭接触者的流感预防效果医学前沿 支气管低温冷冻术和支气管流变成形术治疗慢性支气管炎普托马尼（pretomanid）普托马尼（pretomanid）是一种新型的口服硝基咪唑嗪类抗菌药。2019年8月，普托马尼被批准作为BPaL方案（贝达喹啉、 普托马尼和利奈唑胺）和BPaMZ（贝达喹啉、 普托马尼、莫西沙星和吡嗪酰胺）方案的一部分用于治疗耐药性肺结核。《开放标签单组研究：高度耐药肺结核的治疗》New England Journal of Medicine，2020年3月 (1)这项开放标签、单组研究的目的是评价贝达喹啉、普托马尼和利奈唑胺联合26周治疗广泛耐药结核病患者、以及治疗无效或因副作用而停用二线治疗方案的多药耐药结核病患者的安全性和疗效。共计109例患者被纳入本研究，治疗结束后6个月时，90%的患者结局良好。11例不良结局包括：7例死亡，2例在随访期间复发。利奈唑胺的预期毒性作用包括周围神经病（81%）和骨髓抑制（48%），这些毒性作用虽然常见，但可以控制，常导致利奈唑胺减量或中断用药。结论：在高度耐药结核病患者中，在治疗结束后6个月时，贝达喹啉、普托马尼和利奈唑胺联合治疗使高比例的患者有良好结局。流行性感冒流行性感冒是甲型或乙型流感病毒导致的急性呼吸道疾病，在世界范围内引起爆发和流行，主要发生在冬季。患者出现上呼吸道和/或下呼吸道受累的症状，伴有全身症状，如发热（37.8°C-40.0°C）、头痛、肌痛和无力。一般人群中流感属于自限性疾病，高危人群中并发症和死亡率增加。流感通过大颗粒飞沫和小颗粒气溶胶传播，潜伏期1-4天，无并发症的患者病程持续1周左右，病毒排出时间为病毒暴露后0.5天到7天，病毒排出的高峰在第2天。高危人群包括：年龄≥65岁，妊娠或产后2周，住在长期护理机构，美国印第安人和阿拉斯加原住民，极端肥胖者（BMI≥40kg/m2)，慢性疾病患者，糖皮质激素或免疫抑制治疗的患者。《回顾观察性研究：老年人流感疫苗接种对住院和死亡率的影响》Annual of Internal Medicine，2020年4月 (2)65岁以上的老年人接种疫苗有临床获益的证据非常缺乏，研究者设计了一项“断点回归”分析，他们通过英国7个大型临床数据库分析了疫苗接种率和流感相关疾病。研究发现成人疫苗接种率在65岁这一年，从34%提高至57%。重度呼吸系统疾病均随着年龄的增长而升高，平滑地通过了65岁这一门槛，没有出现急剧下降。假如每年接种流感疫苗的确能给65岁以上的老年人带来明显临床益处的话，预期应出现急剧下降。结论：老年人接种流感疫苗充其量只有很小的直接获益。《双盲随机对照研究：巴罗萨韦对流感家庭接触者的流感预防效果》New England Journal of Medicine，2020年7月 (3)巴罗萨韦在家庭环境中的暴露后预防效果尚不明确。这项多中心、双盲、随机、安慰剂对照试验，在确诊流感病例的545个家庭的752个接触者中，将参与者随机分为两组，分别接受巴罗萨韦或安慰剂单剂给药。巴罗萨韦预防组患临床流感显著低于安慰剂组（1.9% vs. 13.6%；P＜0.001）。巴罗萨韦在高危、儿童和未接种疫苗的参与者的亚组中有效。两组的不良事件发生率相似（巴洛沙韦组22.2%和安慰剂组20.5%）。结论：单剂巴罗萨韦显示出显著的流感病毒暴露后预防效果。流行性感冒的治疗抗病毒治疗包括：神经氨酸酶抑制剂（奥司他韦、扎那米韦和帕拉米韦），流感病毒cap-依赖性核酸内切酶选择性抑制剂巴罗萨韦（baloxavir），金刚烷胺类（金刚烷胺和金刚乙胺）。《开放标签随机对照研究：流感样疾病的治疗中加用奥司他韦的疗效研究》Lancet，2020年1月 (4)研究目的是确定流感样疾病患者在常规初级护理中加入奥司他韦抗病毒治疗是否会缩短康复时间。这项开放标签的、实用的、适应性的、随机对照试验中，将奥司他韦添加到常规治疗中。研究纳入3266名参与者，其中52%经证实感染了流感。总体而言，奥司他韦组的患者恢复时间较短，绝对缩短1.20天。对于没有合并症的、

FDA 治疗高度耐药肺结核的新药NEJM 巴罗萨韦对流感家庭接触者的流感预防效果医学前沿 支气管低温冷冻术和支气管流变成形术治疗慢性支气管炎普托马尼（pretomanid）普托马尼（pretomanid）是一种新型的口服硝基咪唑嗪类抗菌药。2019年8月，普托马尼被批准作为BPaL方案（贝达喹啉、 普托马尼和利奈唑胺）和BPaMZ（贝达喹啉、 普托马尼、莫西沙星和吡嗪酰胺）方案的一部分用于治疗耐药性肺结核。《开放标签单组研究：高度耐药肺结核的治疗》New England Journal of Medicine，2020年3月 (1)这项开放标签、单组研究的目的是评价贝达喹啉、普托马尼和利奈唑胺联合26周治疗广泛耐药结核病患者、以及治疗无效或因副作用而停用二线治疗方案的多药耐药结核病患者的安全性和疗效。共计109例患者被纳入本研究，治疗结束后6个月时，90%的患者结局良好。11例不良结局包括：7例死亡，2例在随访期间复发。利奈唑胺的预期毒性作用包括周围神经病（81%）和骨髓抑制（48%），这些毒性作用虽然常见，但可以控制，常导致利奈唑胺减量或中断用药。结论：在高度耐药结核病患者中，在治疗结束后6个月时，贝达喹啉、普托马尼和利奈唑胺联合治疗使高比例的患者有良好结局。流行性感冒流行性感冒是甲型或乙型流感病毒导致的急性呼吸道疾病，在世界范围内引起爆发和流行，主要发生在冬季。患者出现上呼吸道和/或下呼吸道受累的症状，伴有全身症状，如发热（37.8°C-40.0°C）、头痛、肌痛和无力。一般人群中流感属于自限性疾病，高危人群中并发症和死亡率增加。流感通过大颗粒飞沫和小颗粒气溶胶传播，潜伏期1-4天，无并发症的患者病程持续1周左右，病毒排出时间为病毒暴露后0.5天到7天，病毒排出的高峰在第2天。高危人群包括：年龄≥65岁，妊娠或产后2周，住在长期护理机构，美国印第安人和阿拉斯加原住民，极端肥胖者（BMI≥40kg/m2)，慢性疾病患者，糖皮质激素或免疫抑制治疗的患者。《回顾观察性研究：老年人流感疫苗接种对住院和死亡率的影响》Annual of Internal Medicine，2020年4月 (2)65岁以上的老年人接种疫苗有临床获益的证据非常缺乏，研究者设计了一项“断点回归”分析，他们通过英国7个大型临床数据库分析了疫苗接种率和流感相关疾病。研究发现成人疫苗接种率在65岁这一年，从34%提高至57%。重度呼吸系统疾病均随着年龄的增长而升高，平滑地通过了65岁这一门槛，没有出现急剧下降。假如每年接种流感疫苗的确能给65岁以上的老年人带来明显临床益处的话，预期应出现急剧下降。结论：老年人接种流感疫苗充其量只有很小的直接获益。《双盲随机对照研究：巴罗萨韦对流感家庭接触者的流感预防效果》New England Journal of Medicine，2020年7月 (3)巴罗萨韦在家庭环境中的暴露后预防效果尚不明确。这项多中心、双盲、随机、安慰剂对照试验，在确诊流感病例的545个家庭的752个接触者中，将参与者随机分为两组，分别接受巴罗萨韦或安慰剂单剂给药。巴罗萨韦预防组患临床流感显著低于安慰剂组（1.9% vs. 13.6%；P＜0.001）。巴罗萨韦在高危、儿童和未接种疫苗的参与者的亚组中有效。两组的不良事件发生率相似（巴洛沙韦组22.2%和安慰剂组20.5%）。结论：单剂巴罗萨韦显示出显著的流感病毒暴露后预防效果。流行性感冒的治疗抗病毒治疗包括：神经氨酸酶抑制剂（奥司他韦、扎那米韦和帕拉米韦），流感病毒cap-依赖性核酸内切酶选择性抑制剂巴罗萨韦（baloxavir），金刚烷胺类（金刚烷胺和金刚乙胺）。《开放标签随机对照研究：流感样疾病的治疗中加用奥司他韦的疗效研究》Lancet，2020年1月 (4)研究目的是确定流感样疾病患者在常规初级护理中加入奥司他韦抗病毒治疗是否会缩短康复时间。这项开放标签的、实用的、适应性的、随机对照试验中，将奥司他韦添加到常规治疗中。研究纳入3266名参与者，其中52%经证实感染了流感。总体而言，奥司他韦组的患者恢复时间较短，绝对缩短1.20天。对于没有合并症的、

In this podcast, Erin Michos, MD, talks about her latest study on how the influenza vaccine effects mortality and morbidity outcomes among patients with established cardiovascular disease. More at www.consultant360.com/cardiology

Receiving the influenza vaccine has always been important for patients with kidney disease, but the COVID-19 pandemic makes influenza vaccinations even more crucial now. Listen to this podcast, in which Mandy Tilton, DNP, MSN, MBA, RN, CNN, chief nursing officer for DaVita Kidney Care interviews Jeffrey Giullian, MD MBA, FASN, chief medical officer for DaVita on why influenza vaccination is so crucial and whom he recommends be vaccinated during the pandemic. Dr. Giullian and Mandy also dispel some myths about the flu vaccine, state which form of the vaccine is most effective, discuss the benefits and safety concerns of getting vaccinated during spikes of COVID-19 prevalence in patients’ communities and provide guidance for clinicians in speaking with patients about influenza vaccination. Podcast Transcript: Mandy Tilton, DNP, MSN, RN (00:44): Hello and welcome to the DaVita Medical Insight Podcast. My name is Mandy Tilton and I have the honor of being the chief nursing officer for DaVita Kidney Care. I'm excited today to be joined on the phone with Dr. Jeffrey Guillian, who is our chief medical officer for DaVita, and today we will discuss the importance of influenza vaccination during the COVID-19 pandemic. Thank you for joining us, Dr. G. Dr. Jeffrey Guillian (01:12): Hey Mandy, I'm glad to be able to speak with you on such an important and timely topic. Mandy Tilton, DNP, MSN, RN (01:18): Timely it is. Receiving the influenza vaccine has always been important, but why does the COVID-19 pandemic make it even more crucial now? Dr. Jeffrey Guillian (01:29): Well, Mandy, as I'm sure you can imagine, the flu season is going to be particularly complicated this year given the similarities in symptoms between influenza virus and COVID. And more than any other year, it's really important that all patients and teammates get vaccinated for the flu. Last season, unfortunately, less than half of all Americans got a flu vaccine and at least 410,000 people were hospitalized. Dr. Jeffrey Guillian (01:54): And remember, that although we don't yet have a vaccine for COVID, we do have a vaccine for the flu. And by getting the flu vaccine, you are also helping to protect the people around you. And this is something known as herd immunity. If the majority of the population is vaccinated against the flu, it then reduces the entire community's risk, particularly for vulnerable patients. And preventing the flu supports good stewardship of resources. Even if your illness doesn't require a hospitalization, it helps avoid visits to the doctor, where you might go if you want to confirm that you actually do have the flu. Mandy Tilton, DNP, MSN, RN (02:31): And knowing all of this, who do you think should be recommended to obtain influenza vaccination during the COVID-19 pandemic? Dr. Jeffrey Guillian (02:41): Well, annual flu vaccine is recommended for everyone six months of age or older, so that's certainly all of us listening, except for rare exception, because it is an effective way to decrease the flu illness, decrease hospitalizations, and certainly to decrease deaths. During the COVID-19 pandemic, reducing the overall burden of respiratory illness is an important way to protect vulnerable populations at risk for severe illnesses, and it protects the health care system, and it protects critical infrastructure. Dr. Jeffrey Guillian (03:12): And I want to highlight one vulnerable population, and that's obviously our patients, those with kidney disease. This group of individuals is at high risk for both severe COVID and severe flu. Clinicians should use every opportunity during the influenza vaccination season to administer influenza vaccines to every eligible person. And time is of the essence. It takes around two weeks after the vaccination to achieve immunity, so don't wait until your friend or your neighbor tells you that they've got the flu. Get vaccinated now. Dr. Jeffrey Guillian (03:45): And that brings up an important point. I have certainly heard some people say they are planning on getting the flu vaccine this year because they're already wearing a mask. Now, Mandy, what is your suggested guidance for clinicians who are approached with this thought, by either their patients or their colleagues? Mandy Tilton, DNP, MSN, RN (04:01): Well, that is an important thing to cover. A mask is great and it is a really important barrier for infections, but it's certainly not perfect for stopping the spread of flu. I would encourage us to think about it this way. When we get into cars, we put on seatbelt. I'm guessing most of us all do that even though our car may have safety features like airbags, but we want to keep ourselves as safe as possible. And while the airbags are great and helpful, combined with the seatbelt, they're even better. The same is really true when we think about fighting the flu. Masks are great. In this case, they're your airbags. The vaccine, however, is your seatbelt. Mandy Tilton, DNP, MSN, RN (04:47): And while we're on the subject of dispelling this, can you help us answer a question that many of us are hearing from patients and others? And that question is, can I get the flu from the flu shot? Dr. Jeffrey Guillian (05:02): No, you cannot. You absolutely cannot get influenza from the flu shot. You can get a sore arm, and trust me, I just got my flu shot and my arm was sore. And you can get some achiness, which is proof that your immune system is waking up and becoming activated, but you cannot get the influenza virus itself. Real influenza is a life-threatening viral infection. Dr. Jeffrey Guillian (05:25): Help me, Mandy, if individuals do want to get the flu vaccine, what is your suggested guidance on receiving the nasal flu preparation in its place? Mandy Tilton, DNP, MSN, RN (05:36): The injectable form of the vaccine has proven to be more effective, but even the nasal option is more effective against influenza than receiving no vaccine at all. It's important to remember though, that the nasal spray is not for everyone, particularly those with a compromised immune system. If you or a patient are interested in the nasal spray vaccine, please do first discuss this with your physician. Mandy Tilton, DNP, MSN, RN (06:06): Dr. G, can you help provide some insight on whether the influenza vaccine will protect individuals against COVID-19? Dr. Jeffrey Guillian (06:16): Well, sure, Mandy. I think it's important to remember that getting an influenza vaccine will not protect against COVID-19 directly; however, influenza vaccination has many other important benefits. Influenza vaccines have been shown to reduce the risk of getting the influenza virus and the illness, and hence hospitalizations and deaths. And getting an influenza vaccine this fall will be more important than ever, not only to reduce your risk from the flu, but also to help conserve potentially scarce healthcare resources as we discussed earlier. Many intensive care units are already full with people with COVID. Dr. Jeffrey Guillian (06:52): Now, Mandy, how would you suggest clinicians respond to patients who wonder if it's safe to get an influenza vaccine if COVID-19 is spreading in their community? Mandy Tilton, DNP, MSN, RN (07:01): Well, as clinicians, we can remind patients to practice everyday preventative actions and follow CDC recommendations for things like running essential errands. We can tell patients to ask their doctors, pharmacists, or health departments whether they are following the CDC's vaccination pandemic guidance. And any vaccination location following CDC's guidance should be a safe place for them to obtain their influenza vaccination. Mandy Tilton, DNP, MSN, RN (07:36): I think we've covered a lot, but do you have any additional guidance for clinicians as they speak with patients about the influenza vaccine? Dr. Jeffrey Guillian (07:45): Absolutely. Please remember, people call lots of bad colds the flu, and this is unfortunate and it's not accurate. The real influenza A and B viruses can be life-threatening and make you feel much, much worse than a bad cold. The flu vaccine doesn't stop you from getting a cold, even a bad one, it does, however significantly reduce the risk that you or your patients or your loved ones will get the actual flu, and that, that might just save a life. Mandy Tilton, DNP, MSN, RN (08:18): Well, Dr. G, thank you for joining me and discussing the importance of influenza vaccination during this ongoing COVID-19 pandemic. Dr. Jeffrey Guillian (08:28): Well, thanks for having me, Mandy. I appreciate you having this opportunity. Mandy Tilton, DNP, MSN, RN (08:32): And listeners, thank you all for tuning in and be sure to check out other DaVita Medical Insights episodes for more kidney care educational podcasts. You can also find additional kidney care thoughts, leadership and industry news by following @DaVitaDoc on Twitter.

Este podcast destaca la importancia de la vacuna contra la influenza para todos los niños, incluso aquellos con necesidades de atención médica especiales.

Dr. Pete Mikkelsen busts the myths around flu vaccinations and explain why they are important to get each year.

Four experts provide need-to-know information about safe influenza vaccination during the COVID-19 pandemic. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/938321?src=mkm_podcast_addon_938321

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 6, 2020 issue

This podcast highlights the importance of all children - including those with special health care needs - receiving flu vaccinations.

Commentary by Dr. Valentin Fuster

Barbara Resnick, PhD, CRNP is a Professor in the Department of Organizational Systems and Adult Health at the University of Maryland School of Nursing, co-directs the Biology and Behavior Across the Lifespan Research Center of Excellence, holds the Sonya Ziporkin Gershowitz Chair in Gerontology, and does clinical work at Roland Park Place. Her research program is focused on optimizing function and physical activity and other health promoting behaviors among older adults and testing implementation of interventions in real world settings.  Dr. Resnick has over 250 published articles, numerous chapters in nursing and medical textbooks, and books on Restorative Care and Resilience. She is the editor of Geriatric Nursing, an associate editor and on editorial board for numerous journals.  She has held leadership positions in multiple organizations including Presidency of the American Geriatrics Society and the Gerontological Society of America and has been recognized for numerous national awards.   References: Flu Fact Sheets National Adult Vaccination Program Newsletters Recording Date: 8/27/2020 Available Credit: 0.25 CMD-Clinical

--{ "Pilgrim's Process--- Breaking Commandments We did Flout, Nervously, One-by-one We Ventured Out, Clutching Talismans to Ward Off Disaster, Fauci Amulets, Chants to Gates the Master, Our Unworthy Faces We Did Cover Magic Spacing 6 Feet, One From the Other, Sprinkling Holy Bleach Water on the Hand We Approached the Barrier, Told to Stand, The Master's Priest Pointed Wand at Head, 'Temp's O.K. He's Not Yet Quite Dead," Each One Passed Through the Ordeal Ritual, Cell-Phone Showed Happy Green Emoji Virtual, Almost at the Store Where Food Does Dwell, Black-Clad Master's Man Brought Down Hell, After a Solemn Top to Toe Bodily Scan, He Declared me a Useless Non-Essential Man, So No Food for Me, Homeward I Did Lean, Cell Phone Began Blaring "Quarantine!" "An Infectee Was in Your Close Vicinity, Stay Home, Hand Wash to The Corona Divinity" © Alan Watt }-- Aldous Huxley, Suggestible People, E. Bernays, Mike Wallace - Pay with Our Tax Dollars for the Studies that Manipulate Us; Managed like Cattle; Behaviourists - Hundred Year Business Plans - British Empire and Banking System; America's Federal Reserve (Private Banks) - Reign of Terror on the Public - Part One, 9/11, The Towers; Part Two, The Corona - Lockdown, Herd Immunity - Problems with Testing - Vaccine Industry - Elimination of Privacy - UK, Bristol Hospital, Social Distancing - A Second Wave, Outbreak - Alan Dershowitz, States can Mandate Vaccines - Tyrants, Depravity and Slaughter, Caligula, Nero, Bolsheviks, Marquis de Sade, Lenin - We're in a Revolution NOW - Releasing Prisoners During Revolutions - Virus Magic with Talismans of Face Masks, Hand Sanitizer - Trained Public that Computers are Gods White Magic, Black Magic - Knut Wittkowski - Prof. Dolores Cahill - Gain of Function - Bioweapons, CIA - Book, Deadly Allies, Canada's Secret War - Tainted Blood from Hemophiliacs, B. Clinton Sold to Lab in Canada - Eugenics - Population Matters - The Club of Rome - WHO - Sustainability - Bill Gates - The Disgusting Way of the Elderly have Been Treated During this Pandemic is Pure Eugenics - Bioethics Committees - Gates, Reimagining Education - North Carolina, Wuhan, Fauci Authorizing Transfer of Virus to China - Fauci Said the Virus Probably Just Evolved by Itself - Journalism, Leveson Inquiry - Public-Private - Prince Charles - Television Series, Dad's Army; Rationing, "There's a War On, You Know" - Post-Service Economy - Trading Blocs - Humiliation Doesn't Stop, Airports, Manacles - Trump, Military will Be Used for Vaccinations - Terminology that Shames You; Silencing Debate - Eliminating Religion - Clapping for the NHS - Police - Jacques Ellul - Italian MP Sara Cunial wants Bill Gates Arrested in Italy for Crimes Against Humanity; Event 201 - GAVI Alliance - Follow the Stars - Censorship - Bertrand Russell - Scientific Tyranny will Be Brutal - Please visit www.cuttingthroughthematrix.com to Donate - Euthanasia - Article, Coronavirus ‘did NOT come from animals in Wuhan market' - Article, SARS-CoV-2 is Well Adapted for Humans - Trump's Operation Warp Speed Vaccine Czar Oversaw an Infamously Botched Vaccination - Cytokine Storm; Influenza Vaccination and Respiratory Virus Interference Among Department of Defense Personnel During the 2017-2018 Influenza Season - Mercola Article, Robert F. Kennedy, Jr. - Going into Austerity - 2014, This Flu Shot Is Not Like the Others; Novartis, Flucelvax is Grown in Kidney Cells from Dogs - 2018 Article, Dr. Mercola, Flu Vaccine Grown in Dog Kidney Cells Another Failure - Lysenko, a Favorite of Stalin, Attempted to Force Plant Evolution; Your Immune System's Response to Flu Vaccine Can Make You More Susceptible to the Flu; Heterologous Immunity - Children Who Get Seasonal Flu Shots are More at Risk of Hospitalization than Children Who Do Not - Florida Health Department Manager Told to Delete Coronavirus Data Forced to Resign, She says - Antibodies - Moderna - They're All in Bed Together at the Top - HIV/AIDS - All Adults in England to Be Deemed Organ Donors in 'opt-out' System - Article, COVID-19 Turning Out to Be Huge Hoax Perpetrated by Media - Alan Dershowitz: States Can 'Absolutely' Mandate Vaccinations - Article, More Than Stimulus Checks: How Covid-19 Relief Might Include Mandated Vaccines - COVID-19 Data Sharing with Law Enforcement Sparks Concern - Johns Hopkins Bloomberg School Offering New Free Online Course To Train COVID-19 Contact Tracers For New York State - New York City Partners with Salesforce on Coronavirus Contact Tracing Program - Contact Tracing; Stasi - California Biopharmaceutical Company Claims Coronavirus Antibody Breakthrough - Speaking Loudly Could Help Spread Virus, Study Finds - The US is Dramatically Overcounting Coronavirus Deaths - 2019, Alan Dershowitz asks Judge to Dismiss Epstein Victim's Defamation Case - Peter Hitchens: Furlough Billions? Just a Giant Payday Loan in YOUR Name - Ontario Extends All Emergency Orders, Including Limits on Social Gatherings - States Ordered Nursing Homes to Take COVID-19 Residents, Thousands Died - Dr. Daniel Erikson and Dr. Knut Wittkowski - Prof. Dolores Cahill, Herd Immunity - A Complete Revolution, A War on the Public, Starting with a War of Terror - The Gang of Thieves at the Top, A Parcel of Rogues - Keep Your Talismans and Your Eyes Wide Shut Masks - Don't Panic - Emperor Fauci, Things Will Never Be the Same Again - Please Visit My Website, www.cuttingthroughthematrix.com and Make a List of All My Official Sites, and Please Donate. *Title and Dialogue Copyrighted Alan Watt - May 24, 2020 (Exempting Music and Literary Quotes)

--{ "Behold the Devil's Crossroads Junction, Where Scientists Meet Gain of Function." © Alan Watt }-- Bilderberg Group; G8, G20, Gee Whiz - Catching a Wild Pig - BIT, Behavioural Insights Teams - COVID-19 Terror Campaign on the Public - DARPA, Chipping, Control Nervous System - Mapping the Brain - Rumsfeld, Unknown Unknown - Control Freaks, Successful Psychopaths - MasoniChip; Masonic Child Identification - Societies and Secrets - Knights Templar - Dirty Tricks in Alternative Media; CIA Set Up the Patriot Radio Business - George Bush, New World Order Coming into View - PNAC, Project for the New American Century - Julian Huxley - Free Trade, Moving Manufacturing to China; Most Favoured Nation Trading Status - CFR Article, Bypassing the American Constitution - Bo Gritz, a Plant in Patriot Radio - Hussein - Operation Iraqi Freedom - Kissinger, Brzezinski - Plunder, Divvy Up the Middle East Oil Fields; Tony Blair - Event 201 - Bring You Back to Pre-Industrial Climate - Charles Galton Darwin; Galton, Darwin, Wedgwood Families, Elite Breeding - Oneida Community Breeding Program; Yale, Eugenics - Scientific Socialism - Kissinger, Greatest Threat Overpopulation - Georgia Guidestones - Manley P. Hall - Carroll Quigley, In Wartime, Huge Changes can Be Accomplished Quickly - Cultural Contamination Since the 1960s - Giving the Younger Generation with a Completely Different Set of Values - 9/11 Part Two - Austerity - Substitutes for Meat - Oscar Wilde - Wartime Propaganda, How to Wash Your Hands - Tracking Apps - Devalued Currency - Club of Rome, Man is the Enemy - Leni Riefenstahl - Corporate Fascism - Peter Hitchens - New Type of Police are Thugs - British Scientists say the Coronavirus Outbreak May have Started as Early as September - Coronavirus has been in California 'a lot longer than we believed' with Cases as Early as December - Biolabs - Should we be Making Potential Pandemic Pathogens in the Lab - Marc Lipsitch (2016) - Movie, The Andromeda Strain - Movie, Twelve Monkeys - Population Control Policies to Combat Climate Change Prove Deadly, Demographer says; Paul Ehrlich - Conference of Parties, Climate Change - Artificial Egg Made from Plants Backed by Bill Gates - No More Beef and Cheese: Go Vegetarian, by Order of Government Food Police (2010) - Folk Choose Not to Notice Things - Article, Robert F. Kennedy Jr: Bill Gates Is Obsessed With Vaccines And ‘Seems Fueled By A Messianic Conviction' That He Is Destined To ‘Save The World With Technology And A God-like Willingness To Experiment On The Lives Of Lesser Humans' - Royal Institute for International Affairs - Council on Foreign Relations - The Lucky Gene Club - John F. Kennedy Interview with Bill Gates, 1997, George Magazine; Gates says He Funds Population Control - Bill Gates Father, Julian Huxley, Planned Parenthood - "Change" - Please Donate, www.cuttingthroughthematrix.com; Stubborn Celtic People with an Allergy Against Tyranny - Disinformation, Counter-Intelligence; Divide and Conquer - Bringing Politics into Coronavirus Story - Chips and Tattooing - Still Your Mind - Leveson Inquiry - Obey Authority; Millions Slaughtered in Soviet Era - George Soros - James Bond Villains were Wealthy Men - Fauci, Gates, Vaccines - IBM, Cardex System for German Nazi Party, Tattooed; Gates' Vaccine Chip, Tattoo, Data Collection - The New Klondike - Movie, Fortress - Movie, V for Vendetta; Permanent Emergency Government; The Disgust the Scientific Elite have for People Who Comply - David Suzuki, People are Maggots - Technocracy, Efficiency - Vaccine Klondike - These Vaccines are to Permanently Change the Cells in Your Body - Selling Laboratory Animals for Food - Prosecutors Charged Harvard Professor, Charles Lieber, Department Chair of Chemistry and Chemical Biology for Participation in China's Program to Attract Researchers - Digging Up Frozen Corpses from 1918 Flu Pandemic; Made the Virus More Potent - The One Good Thing about the Atom Bomb - James Bond Movie, Moonraker - Gain-of-Function Research too Dangerous to Do Inside U.S., so Give it to China to Do - HIV Inserts - Maurice Strong regarding U.N. Biodiversity Treaty, said By the Time this is Finished, Humans will Wish They Had the Same Rights as a Tree - Chinese Infiltration of US Labs Caught Science Agencies Off Guard - China's Thousand Talents Plan - Apple, Google to Harness Phones for Tracking Virus Infections - Trudeau Defends New Flights Bringing Canadians Home from Across the Globe - Contact Tracing Apps - Movie, Metropolis - Israel Shin Bet to Use the Cellphone Data to Fight Contagion - Ford Motor Company Tests Buzzing Wristbands To Keep Workers Six Feet Apart - Pink Floyd's The Wall; You're a Brick in the Wall, Do What You're Told - Wear Masks, Don't Wear Masks - A Big Experiment, Pavlov's Dogs, Pavlovian Human Experimentation; Psychological Warfare is Really Happening - Spies in Your Phone, Israel's NSO Group - Contact Tracing, Queensland, Australia - Asymptomatic Carriers - Convincing Australians to Use Government-Sponsored Tracing Apps - Singapore - Moscow Launches Contact Tracing App - New Normals - Illinois County Must Hand Over Coronavirus Patients' Names to Police, Judge Rules - COVID-19 to Have 'immediate and drastic' Impact on Canadian Meat Supply - Why Americans May See a Meat Shortage During the Coronavirus Outbreak - Global Food Supply Chains Beginning to Erode - WWII Propaganda on Food Rationing - George Orwell - Italian Beachtowns Plan "Plexiglass Cages" To Enforce Safe-Sunbathing This Summer - U.S. Government Gave $3.7million Grant to Wuhan Lab at Center of Coronavirus Leak Scrutiny - Coronavirus Vaccine could Be Ready in Six Months - Can No Longer Sue Vaccine Manufacturers for Damages - Senator Dr. Scott Jensen from Minnesota, Hospitals Get Paid More to List Patients as COVID-19 and Three Times as Much if the Patient Goes on Ventilator - In March, US Deaths from COVID-19 Totaled Less Than 2 Percent of All Deaths - Ron Paul, Health Care Patriot Act? - Armed Forces Health Surveillance Branch Study in the Journal Vaccine Titled, Influenza Vaccination and Respiratory Virus Interference among Department of Defense Personnel During the 2017–2018 Influenza Season - Chinese Doctor Shi Zhengli Ran Coronavirus Research in Wuhan After US Project Was Shut Down by DHS in 2014 for Being Too Risky - Lab-Made Coronavirus Triggers Debate; The Creation of a Chimeric SARS-like Virus has Scientists Discussing the Risks of Gain-of-Function Research - Coincidence? Imperial College in UK is Origin of Coronavirus Panic and Global-Warming Panic - Neil Ferguson - Medical Student Charged With Trying To Smuggle Cancer Research From Boston To China - ‘Julian Huxley and the Continuity of Eugenics in Twentieth-century Britain' - Medical Student Charged With Trying To Smuggle Cancer Research From Boston To China - Thomas More - Don't Get Discouraged. *Title and Dialogue Copyrighted Alan Watt - Apr. 19, 2020 (Exempting Music and Literary Quotes)

It's National Influenza Vaccination Week, and Dr. Salwitz & Chris welcome Dr. Tanaya Bhowmick & RWJUH Director of Infection Prevention Pat Lafaro to the show to discuss the flu season and infection prevention in the hospital. Next, Dr. Andy Anderson, CEO of the Rutgers-RWJBH Combined Medical Group, joins the show to talk about building one of the largest physician practices in the country.

Winter is coming…and with it, the onset of flu season. In this episode, Jean-Marie Pflomm, PharmD, Editor in Chief of The Medical Letter, decodes flu vaccines: trivalent vs quadrivalent, live attenuated vs inactivated, and much more.

Flu season is nearly here, so it’s time to get your flu shot. Jade Elliott sat down with Dr. Per Gesteland, a pediatric hospitalist from the University of Utah School of Medicine and Intermountain Primary Children’s Hospital, on this episode of the Baby Your Baby Podcast to discuss the importance of the vaccine and why you … Continue reading Flu season and the influenza vaccination →

Flu season is nearly here, so it's time to get your flu shot. Jade Elliott sat down with Dr. Per Gesteland, a pediatric hospitalist from the University of Utah School of Medicine and Intermountain Primary Children's Hospital, on this episode of the Baby Your Baby Podcast to discuss the importance of the vaccine and why you … Continue reading Flu season and the influenza vaccination → See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this podcast, MeiLan Han, MD, discusses influenza vaccination for patients with chronic obstructive pulmonary disease (COPD), the challenges associated with vaccinating this population, and the conversations you should be having with your patients. More at: www.consultant360.com/pulmonology.

Dr Gaurav Gupta talks about the recent increase in the influenza cases across the world including India, and recommendations by certain schools that have day boarding, residential schools, hostels to vaccinate children with Influenza vaccination before coming back from the winter break , is this a good idea? --- Send in a voice message: https://anchor.fm/gaurav-gupta6/message

Dr Gregory Poland, from Mayo Clinic, Rochester, speaks about influenza vaccination in the elderly, how the approval of baloxavir marboxil will impact that patient population, and more.

Dr Joseph Bocchini, president of the National Foundation for Infectious Diseases, discusses influenza vaccination, the 2018-2019 season, common misconceptions about the vaccine, and more.

It's flu shot season, so we're taking a pseudo-systematic review of influenza vaccination in patient receiving chemotherapy. Questions addressed include: How effective is influenza vaccination for cancer patients? What's the optimal timing of vaccination during chemo?

Dr. Douglas Opel is an assistant professor of pediatrics at the University of Washington School of Medicine. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.J. Opel, J.A. Sonne, and M.M. Mello. Vaccination without Litigation - Addressing Religious Objections to Hospital Influenza-Vaccination Mandates. N Engl J Med 2018;378:785-8.

Host: Jennifer Caudle, DO Guest: Lisa Ipp, MD Although most college students in the U.S. believe it is important to get an annual influenza vaccine, less than half say they typically get vaccinated, according to results from a new National Foundation for Infectious Diseases (NFID) survey. Motivating college students to get their annual flu vaccinations remains a public health challenge that many health care officials have struggled to overcome. Host Dr. Jennifer Caudle chats with Dr. Lisa Ipp about the results and takeaways from this survey and what methods and strategies would be the most effective in encouraging more students to get vaccinated. Dr. Ipp is a Associate Professor of Clinical Pediatrics at Weill Cornell Medicine and Associate Director of Adolescent Medicine at New York-Presbyterian Komansky Children’s Hospital. She also serves as a board member for the National Foundation for Infectious Diseases (NFID)

Learning Objectives: Discuss the 2017-2018 American College of Advisory Committee on Immunization Practices (ACIP) 2017-2018 Seasonal Influenza Vaccine. Review age recommendations, high-risk populations and contraindications for seasonal influenza vaccination. Discuss best practices and dispel myths your patients may believe that prevent influenza vaccination.

This episode features Dr. Sonja Rasmussen, discussing infant protection against influenza illness through maternal immunization (starts at 00:44); and Dr. Karl Fields, discussing outcomes for patients with degenerative meniscal tears, comparing meniscectomy with physical therapy (starts at 13:38). Dr. Nancy Sokol hosts.

Interview with Carlos G. Grijalva, MD, MPH, author of Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination

Interview with Jacob A. Udell, MD, MPH, FRCPC, author of Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients: A Meta-analysis

Interview with Melissa S. Stockwell, MD, MPH, author of Effect of a Text Messaging Intervention on Influenza Vaccination in an Urban, Low-Income Pediatric and Adolescent Population: A Randomized Controlled Trial

Jennifer from the SMJ talks to Dr. Millner about how the surprisingly high refusal rate of influenza vaccine among health care personnel might be improved.

Influenza Vaccination Safety for Patients with Myasthenia Gravis by Lorne H. Zinman, MD, MSc, and David N. Juurlink, BPhm, MD, PhD

An interview with Lorne H. Zinman, MD, MSc, FRCP(C), and David N. Juurlink, BPhm, MD, PhD, FRCPC, about the article, Safety of influenza vaccination in patients with myasthenia gravis: a population-based study, Muscle Nerve. 2009 Dec;40(6):947-51. Interviewed by Ted Burns.

An interview with Lorne H. Zinman, MD, MSc, FRCP(C), and David N. Juurlink, BPhm, MD, PhD, FRCPC, about the article, Safety of influenza vaccination in patients with myasthenia gravis: a population-based study, Muscle Nerve. 2009 Dec;40(6):947-51. Interviewed by Ted Burns.

Editorial director and interim editor-in-chief Shawn Kennedy and clinical editor Christine Moffa present the highlights of the October issue of the American Journal of Nursing. Of special note: "Drug Administration Through an Enteral Feeding Tube," by Joseph I. Boullata, and "Influenza Vaccination with a Live Attenuated Vaccine", by Michele Michael.

Editorial director and interim editor-in-chief Shawn Kennedy and clinical editor Christine Moffa present the highlights of the October issue of the American Journal of Nursing. Of special note: "Drug Administration Through an Enteral Feeding Tube," by Joseph I. Boullata, and "Influenza Vaccination with a Live Attenuated Vaccine", by Michele Michael.

Guest: Lisa A. Jackson, MD, MPH Host: Maurice Pickard, MD Do influenza vaccines for the elderly really make a difference? Dr. Lisa Jackson, research professor of epidemiology at the University of Washington and senior investigator at The Center for Health Studies in Seattle, Washington calls into question previous documentation of reducing deaths and hospitalizations in the elderly from flu vaccination. This is based on a fundamental difference between the kinds of people who get vaccines and those who do not. Join host Dr. Maurice Pickard to learn more.

Guest: Anthony Fiore, MD Host: Bruce Bloom, DDS, JD With this year's flu season comes the recommendation from the CDC to extend the age of childhood vaccination past the previous age of 59 months, to 18 years. Why the change, and what are the recommendations based upon? Joining Dr. Bruce Bloom to discuss this year's recommendation is Dr. Anthony Fiore, a vaccination and immunization expert, and medical epidemiologist from the CDC in Atlanta.